Skip to content

ERT (1)

HealthTech·United States·Exited 2026·Held 7yr
Entry
2019
Hold
7yr
Exit
2026

Who owns ERT (1)?

ERT (1) is an American HealthTech company, now owned by Thermo Fisher Scientific, which acquired it in 2026 from Astorg.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Astorg
Most recent investor
Astorg
Astorg VII · 2019 · Buyout
2 ownership periods · full history below

Key facts

HQUnited States
SectorHealthTech
StatusAcquired
Key takeaways
  • ·Fully exited in 2026 to Thermo Fisher Scientific.
  • ·Average hold across 2 realized cycles: 5 years.

Ownership history

2 ownership periods

Exited
Last exited in 2026 to Thermo Fisher Scientific.
Nordic Capital
Nordic CapitalExited 2019
2016 · 2019(3yr) · Nordic Capital Fund VIII · 2013 · Buyout
Secondary · to Astorg

Nordic Capital sold ERT (1) to Astorg in 2019 after 3 years.

Astorg
AstorgExited 2026
2019 · 2026(7yr) · Astorg VII · 2019 · Buyout
Trade Sale · to Thermo Fisher Scientific

Astorg sold ERT (1) to Thermo Fisher Scientific in 2026 after 7 years.

Questions

Who owns ERT (1)?

ERT (1) is now owned by Thermo Fisher Scientific, which acquired it in 2026 from Astorg.

When did Thermo Fisher Scientific acquire ERT (1)?

Thermo Fisher Scientific acquired ERT (1) in 2026, buying from Astorg.

Who did ERT (1) sell to?

Astorg sold ERT (1) to Thermo Fisher Scientific in 2026 (Trade Sale). Nordic Capital sold ERT (1) to Astorg in 2019 (Secondary).

Who has owned ERT (1) over time?

ERT (1) has been through 2 private-equity ownership periods: Nordic Capital · via Nordic Capital Fund VIII · 2016–2019 · sold to Astorg · (Secondary); Astorg · via Astorg VII · 2019–2026 · sold to Thermo Fisher Scientific · (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue